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Abstract 
 
Objectives: To evaluate the evidence with regard to the effectiveness and stability of orthodontic treatment 
interventions for Class II division 2 malocclusion (II/2M) in children and adolescents. 
Design: Systematic review conducted according to the PRISMA statement. 
Methods: The Cochrane Oral Health Trials Register, the Cochrane Central Register of Controlled Trials 
(CENTRAL), MEDLINE and EMBASE were searched to November 2011.  Relevant conference abstracts 
were also screened. No language restrictions were applied.  Inclusion criteria were: clinical studies with > 20 
II/2M subjects where comparisons were made with an untreated II/2 M group or another treated II/2 M 
group or neither.  For included studies ranked best on the hierarchy of evidence, assessments of 
methodological quality and risk of bias were undertaken.  Abstracts and, when appropriate, full papers were 
examined independently by two investigators.  Disagreements were resolved through discussion. 
Outcomes: Treatment changes and/or stability with or without retainers using the following measures: 
skeletal, soft tissue, dental, occlusal changes, gingival health, TMJ status and/or related muscular activity or 
quality of life. 
Results: Of the 322 studies identified in the search, 20 met the final inclusion criteria.  All were at high risk 
of bias. 
Conclusions: Highly biased evidence exists with regard to management and stability of II/2 M.  Guidelines 
are proposed based on current evidence. 
 
Introduction 
 
Class II division 2 malocclusion(II/2M), characterized by retroclination of the upper incisors and a deep 
overbite,1 has a reported prevalence in UK children of 10%.2  A prevalence of 5-12% has been reported in 
other European populations3-6 and 3-4% in US populations7 with the severe manifestation of “cover-bite” 
estimated at almost 2%.8  Although controversy surrounds the accompanying dentofacial characteristics,9,10 
vertical skeletal factors make a greater contribution in more severe forms.11,12  The high lower lip line with 
associated resting pressure (approximately 2.5 times greater than the upper lip resting pressure) has been 
shown to be linked with retroclination of the upper incisors.13,14  A strong genetic input exists with regard to 
the underlying skeletal pattern and dental anomalies, especially the increased prevalence of impacted 
maxillary canines.15 
 
Orthodontic treatment of II/2M is recognized as difficult and prone to relapse.13,14  The randomized clinical 
trial provides the highest quality evidence with regard to effectiveness of treatment interventions and data 
from several trials have enabled meta-analysis to be undertaken on the effectiveness of growth modification 
for Class II division 1 malocclusion.16  Retrospective controlled studies, have some benefit until results from 
prospective studies become available17 and information from these studies have been included in orthodontic 
systematic reviews on Class III treatment and lingual arch space maintenance.18,19  Although RCTs and 
controlled clinical trials (CCTs) have been considered in a previous review,20 until now it would appear that 
no review has addressed all of the prospective and retrospective evidence regarding effectiveness of 
orthodontic treatment and its stability for II/2M. 
 
The aim of this review was to evaluate the evidence with regard to the effectiveness of orthodontic treatment 
and stability for II/2M in children and adolescents and if possible to identify the most effective treatment 
strategies through the use of meta-analysis.  The null hypothesis tested was that there is no difference in the 
effectiveness of any of the treatment interventions or in their ability to promote stability for II/2M.  
Reporting of this review is according to the PRISMA statement.21 
 
Materials and methods 
 
Criteria for selecting studies for the review were as follows: 
 
Study design 
 
Randomized and controlled clinical trials (RCTs and CCTs respectively) were included as these are likely to 
contain acceptable quality evidence.  Prospective and retrospective studies with > 20 subjects per 
intervention group were assessed also.  A minimum sample of 20 was chosen based on the data from 
Stellzig et al.,22 who found that patients with II/2 malocclusion treated with headgear and upper second 
molar extractions had a reduction in the interincisal angle of 12.6o (SD 10.2o) compared with an historical, 
untreated control group.  Using these data we determined that a sample of 30 (i.e. 15 subjects in each group) 
would be sufficient to detect a significant difference between treated and untreated groups with a power 90% 
and P<0.05; however to account for the relatively wide SD in incisor inclination23, which is especially 
relevant to II/2M outcome assessment, as well as to allow for drop-outs and withdrawals, a minimum sample 
size of 20 per group was chosen.  Smaller samples are acknowledged to be of very limited use, particularly 
if cephalometric data are being evaluated.24  Studies where comparisons were made with either an untreated 
II/2M group or to another treated II/2M or neither were included.  Without a control group, very limited 
conclusions regarding outcomes of treatment can be made due to the increased susceptibility to bias.25  
Individual case reports were not considered for analysis due to the poor quality evidence provided. 
 
Participants 
 
Children and adolescents who had treatment for II/2M were included.  Adults (where mean age pre-
treatment was > 18 years) were excluded due to lack of growth affecting treatment outcome.  For studies 
with mixed child/adolescent and adult samples, only data for the former were considered. 
 
Intervention 
 
Cases treated with one arch or two arch full fixed appliances (with or without extractions) were accepted 
including those where Class II elastics were utilized without adjunctive appliances. In addition, removable, 
functional or headgear appliances, in isolation or in combination with fixed appliances, were included.  
Cases treated by a combined orthodontic-orthognathic approach were excluded as the focus was on 
orthodontic treatment only and the resultant stability.  The type of appliance investigated was recorded to 
put studies into homogeneous groups, where meta-analysis was feasible.  
 
Outcome measures 
 
Studies were included if they reported data on treatment and/or stability of treatment with regard to one or 
more of the following measures: skeletal, soft tissue, dental, occlusal changes (preferably assessed with an 
occlusal index), gingival health, temporomandibular joint status or related muscular activity or quality of 
life.  If stability was assessed, patients were followed up for a minimum of 12 months post-treatment, with 
or without retainer(s). 
 
Search methods for study identification 
 
Several sources were utilized as a search confined to Medline only is generally deemed to be inadequate.  
The Cochrane Oral Health Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), 
MEDLINE and EMBASE were searched to November 2011.  Journals which are hand-searched for the 
Trials Register are given on the Cochrane Oral Health Group website (http://ohg.cochrane.org).  To identify 
records, usually three basic sets of terms are used: those that identify records related to the health condition 
of interest (II/2M), those used to identify records related to the intervention being evaluated and finally those 
which identify the type of study design to be included.  As a pilot run of the search strategy incorporating 
type of study design yielded no papers by any database, the search was confined to only two basic sets of 
search terms. 
 
Details of the search strategies developed for all databases are given in Table I. 
 
Other sources 
 
Conference proceedings and abstracts from the British Orthodontic Conference, European Orthodontic 
Conference and the International Association for Dental Research Conference were searched up to 
November 2011.  
 
The references quoted in the studies identified were screened for any further trials and international 
researchers potentially involved in II/2M clinical trials were contacted in an attempt to identify unpublished 
or ongoing RCTs and CCTs.  No language restrictions were applied. 
 
Study selection 
 
The selection of papers, decision about eligibility, study classification and data extraction were undertaken 
independently and in duplicate by two assessors without blinding to the authors, appliance type or results 
obtained.  All disagreements were resolved by discussion. 
 
 
Data extraction and management 
 
The following information was recorded for each eligible study on a customized data collection form: 
initials of reviewer, authors, year of publication, setting of the study, age and gender of the subjects, study 
design, defining criteria for the malocclusion, sample size calculation, treatment type and duration, drop outs 
and type of retention, outcome measures, method(s) of assessment, error study and study results. 
 
The primary outcome measures in the identified studies were skeletal, soft tissue, dental, occlusal or gingival 
changes with treatment or during an observation period.  Secondary outcome measures were 
temporomandibular joint status and quality of life. 
 
Quality assessment / risk of bias assessment of eligible studies 
 
For the eligible studies ranked highest on the hierarchy of evidence,26,27 quality was assessed according to 
the following criteria:  
• sample size reported 
• sample based on power calculation 
• eligibility criteria described 
• random allocation 
• allocation concealment 
• baseline equivalence of groups 
• blinding of participants/caregivers (where possible) 
• blinding of outcome assessors 
• point estimates and variability reported for primary outcome measures 
• appropriateness of statistical analysis 
• extent of drop outs / exclusions (trials using an intention-to-treat analysis were noted) and 
• selective reporting. 
 
For those eligible studies, a description of the quality items was tabulated, together with a judgment of low, 
high or uncertain risk of bias.  Criteria for risk of bias judgments for allocation concealment were according 
to the Cochrane Handbook for Systematic Reviews of Interventions 5.0.2.28 
 
Unit of analyses issues 
 
All eligible studies were assessed for the appropriateness of their analyses. 
 
Assessment of reporting biases  
 
It was planned that if sufficient trials were identified, a funnel plot would be drawn and a formal 
investigation of the degree of funnel plot asymmetry undertaken using the method proposed by Egger.29  
Asymmetry may represent a true trial and effect size relationship, but may also indicate publication bias and 
other biases related to sample size. 
 
Analyses 
 
The characteristics of the eligible studies were used to evaluate their clinical heterogeneity.  Following data 
extraction, it was intended to undertake Cochran’s test for heterogeneity before any meta-analysis, to 
produce forest plots demonstrating the overall effects of the treatment interventions. 
 
Results 
 
As described in the PRISMA statement,21 the review details are given in Figure I. 
 
 
Studies identified  
 
Of the 322 records resulting from the search strategies, only 23 full text articles (and one abstract) were 
retrieved for more detailed evaluation. Of these 3 (plus the abstract) were subsequently excluded (Table II30-
33). Twelve studies (4 prospective; 8 retrospective) dealt with treatment (Table III34-38, Table IV39-47) and 8 
studies (all retrospective) dealt with stability (Table V48-55).  The study types, with numbers per group, were 
as follows:  
• prospective case-control of treatment (1) 
• prospective cohort of treatment (1)  
• prospective case series of treatment (2)  
• retrospective cohort of treatment (4) 
• retrospective case series of treatment (4)  
• retrospective case-control of stability (1) 
• retrospective cohort of stability (1)  
• retrospective case series of stability (6).  
 
Key methodological data are summarized in the Tables indicated.  For those study designs ranked best on 
the hierarchy of evidence, a risk of bias assessment was undertaken.  Both assessors, however, deemed those 
studies to be at high risk of bias (Table VI).  All other designs were deemed to have inherent high risk of 
bias.  
 
Prospective case-control study of treatment for II/2M (Table III)38 
 
This was the only study where comparisons were made with a contemporaneous untreated II/2M control 
group.  The comparisons were based on age and one of three mandibular growth directions; however, it was 
not clear, whether the “matching” of the treatment and control groups was done prospectively or 
retrospectively.  Gender was closely, but not exactly, matched between treated and control groups.  Non-
extraction treatment, started in the late mixed dentition stage for overbite reduction in II/2M subjects with 
mesofacial or brachyfacial growth patterns (normal or reduced lower facial height respectively), led to a 
mean forward movement of B point of 4-5 mm compared with the controls during the treatment period 
(mean duration 2.4 yrs and 2.2 yrs respectively). 
 
Prospective cohort of treatment for II/2M (Table III)34 
 
One study followed II/2M cases treated using functional appliance therapy, preceded in some patients by a 
removable appliance to procline the upper incisors. A distal path of closure was found in 50 per cent of the 
II/2M sample pre-treatment and electromyographic assessment showed masseter and temporalis activity 
became more “normal” during functional appliance treatment.  Additionally, a low gonial angle was 
associated with increased masseteric activity. 
 
Prospective case series of treatment for II/2M (Table III)35,37 
 
Two studies on the same cohort reported the results of upper removable appliance therapy to procline upper 
incisors and reduce the overbite, followed by functional appliance therapy. When the antero-posterior 
distance for the retruded to the intercuspal mandibular position was compared from start of treatment to 
post-incisor proclination, no statistically significant difference was found.  The muscle activity was also 
unchanged on completion of treatment which contrasts with the study by Moss.34  The findings led the 
authors to substantiate the view that the mandible does not position anteriorly during treatment of II/2M. 
 
Retrospective cohort studies of treatment for II/2M (Table IV)22,40,46,47  
 
Selection criteria for II/2M varied between studies so inter-study comparison is not appropriate.  
Extraction22,40,47 and non-extraction40,46 treatments were assessed.   The only study to use an untreated II/2M 
 
control group, compared extraction of four first premolars versus upper second permanent molars.22  The 
control group was derived from the Belfast Growth Study, but it was not clear if there was gender matching 
with the treated groups.  Furthermore, the treated and control groups were not equivalent at baseline 
although almost approximated on completion of treatment.  The amount of crowding in either group was not 
specified.  In addition, there was variation with regard to intrusion mechanics for overbite reduction, as well 
as the use of headgear as an adjunct to fixed appliances in many cases in both extraction groups.  Four 
premolar extractions, rather than upper second permanent molar extractions, produced more retraction of the 
upper lip and less reduction in the interincisal angle; premolar extraction spaces also re-opened at the end of 
treatment in more than 40 percent of cases. 
 
With upper premolar extractions only, wide variation existed in naso-labial angle changes; although there 
was a mean increase of ~2.50 for II/2M, this was not significantly different to the II/1M group.47  Overbite 
was successfully reduced by several treatment approaches; the mean decrease varied from 1.9mm46 to 
almost 5mm40 and the mean decrease in interincisal angle varied from 60 to almost 220 respectively.  
 
Retrospective case series of treatment for II/2M (Table IV) 39,41,44,45 
 
Again, selection criteria for II/2M varied between studies or were not specified.39  Non-extraction 
treatment,39,44  predominantly by functional appliances, appeared to be a common treatment approach but 
two studies did not specify whether extractions were undertaken or not.41,45  Maxillary apical base size was 
the strongest predictor of occlusal change.45   
 
Retrospective case-control study of stability for II/2M (Table V)51 
 
At a mean time of 15.2 years out of retention, the mean relapse in overbite and interincisal angle correction 
was 40% and 59% respectively.  The overbite relapse mirrored that of the reduction in lower anterior facial 
height (almost 40%).  As the incisor segments uprighted, incisor crowding increased especially in the lower 
arch but this varied between individuals.  Lower arch extractions did not appear to increase post-treatment 
overbite if appropriate treatment mechanics were used; rather the initial overbite was the best predictor of 
post-treatment overbite but predictability was not high (R2 = 0.42).  The chance of maintaining an overbite 
<4mm in the long term was deemed to be less than 50%.  Post-treatment vertical facial growth contributed 
to maintenance of overbite correction.  Molar relationship correction was very stable. 
 
Retrospective cohort study of stability for II/2M (Table V)55 
 
Following two-phase (Herbst and fixed appliances) non-extraction treatment and an average of 27 months 
retention, overbite correction was more stable in late (~86%) than in early adolescents (70%).  Molar 
relationship relapsed minimally (5-7%).  
 
Retrospective case series evaluating stability of II/2M treatment (Table V)48-50,52-54 
 
The retention type, duration of retention and treatment approach varied, although non-extraction was again 
favoured across all studies.  The overbite increased post-treatment49,50 with an associated increase in 
interincisal angle49  and relapse in maxillary incisor inclination correction;48,52,54 the latter was found to be 
independent of retainer type and there was large inter-individual variation.52,54  Incisor crowding increased 
simultaneously with overbite relapse48,50 and was more marked in the lower arch,50  supporting the findings 
of Kim and Little.51  Lower incisor proclination and expansion of the intercanine width relapsed.50  The 
former was regarded to be more stable than upper incisor proclination,48 although both incisor segments 
uprighted.48,49,54  The greater the treatment change in upper incisor inclination, the greater the relapse.52,54   
In a sample with a mix of removable and fixed appliance treatments (some combined), a mean value of 25% 
relapse in overbite was found at 2 years post-treatment.52  In other post-retention studies, the mean overbite 
relapse varied from ~20% to ~30% (0.8-1.2mm) when assessed at 2 and 5 years respectively49 to ~26% at a 
mean period of 7 years (0.96mm).50  Time post-retention was correlated with the extent of overbite relapse 
 
and lower incisor irregularity.50  No variables were found to determine the prognosis for overbite stability,50  
with an anterior growth rotation of the mandible evident post-treatment, especially in male subjects.49  
Overcorrection of overbite did not show net improvement at a mean time of 7 years out of retention.50 
 
The level of the lower lip post-treatment had a significant influence on the relapse tendency of the corrected 
incisors relationships.52,53  Although recommended to reduce lower lip coverage to a maximum of 3mm,52 a 
mean decrease of 0.6mm while statistically significant was not judged to be clinically significant.54  At a 
minimum of 3 years post-retention, 10% of upper arches and 30% of lower arches had unacceptable 
irregularity.50  Molar relationship was very stable after correction50 which confirmed the findings of others.51 
 
Due to the heterogeneity of all the included studies, it was not possible to undertake a meta-analysis to 
determine the most effective means of treatment or stability for this malocclusion.  There is insufficient high 
quality evidence to reject the null hypothesis tested in this review. 
 
Discussion 
 
This systematic review found no RCTs investigating the effectiveness and stability of orthodontic treatment 
in children and adolescents with a II/2M, even though evidence of that quality is available for other 
malocclusions.16,57 Unfortunately lack of RCT evidence is a consistent finding in both dental58 and 
orthodontic systematic reviews.59,60 
 
What are the implications of this review for clinical practice? 
 
For ethical, administrative and financial reasons, RCTs are difficult to conduct for II/2M61 as well as for 
other orthodontic questions.17  Furthermore, they appear not to have provided extra knowledge to that 
already available from retrospective studies for treatment of Class II malocclusions,62 but are likely to 
overestimate the treatment effect by approximately 30 per cent.63  All the evidence found in this review was 
deemed to be at high risk of bias.  So one is faced with a dilemma: on what does one base clinical practice 
for II/2M?  Successful correction of II/2M has been achieved over many years (Tables III-V) and in the 
absence of well conducted clinical trials, it seems reasonable to re-visit this evidence in an attempt to 
develop broad guidelines for clinical practice.  This approach adds some additional perspective on II/2M and 
appears to be all that is possible in the short term.  The comments of Litt and Nielsen,64 re-iterated by 
Stellzig et al,22 seem to be echoed even in present times: “The clinical management of II/2M remains a 
“mystery” entailing problems of diagnosis, therapy and retention; when therapeutic aspects are condensed to 
a central topic, these publications are mainly restricted to general guidelines.” 
 
Guidelines for clinical practice and relevance 
 
Based on the limited and highly biased evidence, it is possible to make recommendations only in the 
broadest sense. 
 
Treatment timing and prediction of outcome 
Prospective evidence indicates that to maximize favorable dentoalveolar and soft tissue changes, the facial 
growth pattern should be identified early and the deep overbite managed in a timely manner.38  The 
relevance of this, as indicated by the author, is that the magnitude of mandibular growth will impact on the 
necessary amount of maxillary arch retraction during Class II correction.38  Limited prospective evidence 
exists that growth modification by functional appliance therapy may also “normalize” muscle function,34 
which could assist with stability.  As post-treatment vertical facial growth assists with maintenance of 
stability,51 treatment should be timed to allow for this, where possible. 
 
The size of the maxillary apical base has been suggested as a possible factor to influence the success of 
occlusal correction as it is “conceivable that the larger the transverse and sagittal extent of the maxillary 
apical base, the more unfavourable is the prospect of mechanically correcting II/2M.”45  The authors, 
 
however, acknowledged that other factors, such as growth, patient compliance and operator proficiency are 
all relevant, but were not assessed.  Further work on predictive models for treatment success of II/2M is 
necessary. 
 
Extraction versus non-extraction 
It is suggested that caution be exercised with regard to four first premolar extractions in view of the potential 
detrimental effects on facial profile, overbite and re-opening of the extraction spaces post-treatment.22  
Comparison, however, was made to an upper second permanent molar extraction group, so it is doubtful if 
the groups were comparable pre-treatment.  Nonetheless, the propensity for maxillary extraction spaces 
(mainly first premolar) to re-open post-treatment was also found in another study and led to a greater relapse 
tendency of the corrected upper incisor inclination, particularly the more anterior the extraction;52 this would 
appear to favour extraction further posteriorly in the arch or a non-extraction approach. 
 
Only one study evaluated the soft tissue effects of Class II (II/2M versus II/1M) fixed appliance treatment 
with upper premolar extractions alone (camouflage treatment).47  The authors concluded that such a 
treatment approach is likely to result in a wide variation in lip and upper incisor behavior.  Furthermore, they 
suggested that negative effects on upper lip curve and nasolabial angle are more likely where the upper lip is 
thin pre-treatment and the nasolabial angle is increased.  Upper premolar extractions would appear to be best 
avoided in such cases. 
 
Extractions did not seem to influence the magnitude of overbite correction if adequate appliance therapy was 
used but the authors cautioned about making any inferences from this as the sample size did not allow 
breakdown into further subgroups according to treatment (extraction vs non-extraction), sex or age.51  Non-
extraction treatment,34,44,50-52 however, seems favoured with functional appliances or a removable appliance 
used by several in advance of fixed appliances; this approach takes advantage of vertical facial growth to 
assist overbite correction. 
 
Overbite reduction and correction of interincisal angle 
Overbite may be reduced successfully by several means,40,49,51 but success depends on alteration of 
interincisal angle,48 moving the upper incisors from lower lip control possibly by intrusion 47,53,54 and 
vertical facial growth.48  Correction of upper incisor inclination to as near normal as possible is advised; 
overcorrection is more prone to relapse.53   Based on data from one study, overcorrection of the overbite 
would also appear not to be advisable as changes were not upheld long-term.50  As with all malocclusion 
types, lower arch expansion, either antero-posteriorly or laterally is not recommended,50 unless permanent 
retention is considered. 
 
Retention planning and follow-up 
To maintain overbite and interincisal correction, as well as incisor alignment, long-term retention is 
necessary.54  In growing patients a bite-raising appliance, which also maintains the upper incisor inclination, 
is recommended to combat overbite relapse due to the tendency for anterior mandibular growth rotation.49,54  
Follow-up for 5 years minimum is advised as many skeletal, soft tissue and dental variables showed 
significant change from 2 to 5 years post-retention.49  In addition, at 9 years post-treatment the lower lip 
level contributed to more of the relapse variability than at 2 years post-treatment.54  A tighter control 
schedule or permanent palatal bonded retention is suggested,52 but the type of upper retainer (Hawley or 
palatal bonded retainer) did not appear to influence upper incisor stability at a mean of 3.5 years post-
treatment.54 
 
Stability and prediction of relapse 
Overbite correction appears reasonably stable, with on average ~20% relapse at 2 years post-retention;49 but 
this doubled at 15 years follow-up.51  Upper incisor inclination correction was also reasonably stable.54  
There is great inter-individual variation53 and incisor crowding returned, especially in the lower arch.52   
There was a greater tendency to relapse of the corrected upper incisor inclination where the lower lip line 
was high post-treatment.52,53  For maximum treatment stability, removal of excessive overlap of the upper 
 
incisors by the lower lip has been highlighted as one of the most important treatment objectives.53   Molar 
correction appeared to be particularly stable.51  As it is not possible to predict overbite stability,50 long-term 
retention is recommended.  Clinicians should realise that those patients who present with the most upright 
upper and lower incisors tended to have a deeper initial overbite pre-treatment and a tendency to return to 
their original relationship post-retention;51 particular vigilance should be paid to prescribing retention and 
monitoring occlusal change during and out of retention in these patients.      
 
Implications for future research 
 
Clear and reproducible defining criteria used in sample recruitment/selection should be reported in future 
studies to eliminate the variability of examiner classification of II/2M.65  It is recommended that in order to 
be classified as II/2M, the upper incisor inclination to the maxillary plane or SN line should be greater than 1 
SD beyond the mean for the ethnic group from which the sample is drawn.22  Baseline matching of the study 
samples with regard to age, gender, skeletal pattern, amount of crowding and incisor inclinations is 
important in order to control for growth, in particular, as a confounding factor on treatment outcomes.  
Sample size calculations based on identified outcome measures should also be included in all future studies.  
More complete reporting of statistical analyses is also required with point and related variability data to be 
included for a limited number of relevant and clinically meaningful cephalometric landmarks.  Patient 
reported outcome measures should also be included.66 
 
A contemporaneous control group of II/2M subjects should be used in future comparative studies of 
treatment and stability and not subjects with a Class I occlusion/malocclusion; the former would eliminate 
bias due to secular changes affecting facial growth, which have been observed over recent decades.67  The 
eight-year recruitment period in the study by Woods38 highlights the difficulty of prospectively recruiting a 
treatment and control group for II/2M, despite offering a fee waiver.  Similar difficulty has been encountered 
in a recent RCT.62  In the light of this and the reported prevalence of II/2M, longitudinal multicenter 
international trials are required in order to achieve the sample size required for appropriate statistical 
analyses of treatment and stability outcomes (case–control and preferably randomized clinical trials).  
Recommended for orofacial clefting to recruit sufficient data,68 such multicenter collaborative trials require 
control for racial growth variables for outcome analysis. 
 
Conclusions 
 
Highly biased prospective evidence exists with regard to the effect of late mixed dentition non-extraction 
treatment on facial growth in II/2M.  Prospective and retrospective highly biased evidence appears to favour 
non-extraction treatment and indicates overbite correction to be reasonably stable in the short-term.  
International multicenter collaborative studies are required to gather appropriate epidemiological evidence 
regarding this condition.  Prospective international studies are required (either case-control or randomized 
trials) to provide stronger evidence on treatment and stability for II/2M in children and adolescents. 
 
 
References 
 
1. van der Linden FPGM. Development of the dentition. Chicago: Quintessence Publishing Co. Inc.; 1983. 
2. Foster TD, Day AJ. A survey of malocclusion and the need for orthodontic treatment in a Shropshire 
school population. Br J Orthod. 1974; 1:73-8. 
3. Markovic M. A genetic study of Class II Division 2 malocclusions. Eur J Orthod. 2000; 22:453-4. 
4. Mierut LL. Class II division 2 malocclusions: Frequency and upper incisor aspects. Eur J Orthod. 2000; 
22:602. 
5. Myllarniemi S. Malocclusion in Finnish rural children An epidemiological study of different stages of 
dental development. Suom Hammaslaak Toim. 1970; 66:219-64. 
6. DeBruyne I, Willems G, Carels C, Fieuws S. Prevalence and characteristics of malocclusion in a 
Belgian orthodontic population. [abstract] Eur J Orthod. 2000; 22:575. 
 
7. Massler M, Frankel JM. Prevalence of malocclusion in children aged 14 to 18 years. Am J Orthod. 
1951; 37:751-68. 
8. Peck S, Peck L, Kataja M. Class II Division 2 malocclusion: a heritable pattern of small teeth in well-
developed jaws. Angle Orthod. 1998; 68:9-20. 
9. Karlsen AT. Craniofacial characteristics in children with Angle Class II div. 2 malocclusion combined 
with extreme deep bite. Angle Orthod. 1994; 64:123-30. 
10. Pancherz H, Zieber K. Dentoskeletal morphology in children with Deckbiss. J Orofac Orthop. 1998; 
59:274-85. 
11. Brezniak N, Arad A, Heller M, Dinbar A, Dinte A, Wasserstein A. Pathognomonic cephalometric 
characteristics of Angle Class II Division 2 malocclusion. Angle Orthod. 2002; 72:251-7. 
12. Siriwat PP, Jarabak JR. Malocclusion and facial morphology is there a relationship? An epidemiologic 
study. Angle Orthod. 1985; 55:127-38. 
13. Lapatki BG, Klatt A, Schulte-Monting J, Jonas IE. Dentofacial parameters explaining variability in 
retroclination of the maxillary central incisors. J Orofac Orthop. 2007; 68:109-23. 
14. Lapatki BG, Mager AS, Schulte-Moenting J, Jonas IE. The importance of the level of the lip line and 
resting lip pressure in Class II, Division 2 malocclusion. J Dent Res. 2002; 81:323-8. 
15. Basdra EK, Kiokpasoglou M, Stellzig A. The Class II Division 2 craniofacial type is associated with 
numerous congenital tooth anomalies. Eur J Orthod. 2000; 22:529-35. 
16. Harrison JE, O'Brien KD, Worthington HV. Orthodontic treatment for prominent upper front teeth in 
children. Cochrane Database Syst Rev 2007, Issue 3. Art. No.: CD003452. DOI: 
10.1002/14651858.CD003452.pub2 
17. Johnston LE, Jr. Moving forward by looking back: 'retrospective' clinical studies. J Orthod. 2002; 
29:221-6. 
18. Toffol LD, Pavoni C, Baccetti T, Franchi L, Cozza P. Orthopedic treatment outcomes in Class III 
malocclusion. A systematic review. Angle Orthod. 2008; 78:561-73.20.  
19. Viglianisi A. Effects of lingual arch used as space maintainer on mandibular arch dimension: a 
systematic review. Am J Orthod Dentofacial Orthop. 2010; 138:382 e1-4. 
20. Millett DT, Cunningham S, O'Brien KD, Benson PE, Williams A, de Oliveira CM. Orthodontic 
treatment for deep bite and retroclined upper front teeth in children. Cochrane Database Syst Rev 2011, 
Issue 4. Art. No.: CD005972. DOI: 10.1002/14651858.CD005972.pub2. 
21. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009; 6:e1000097. 
doi:10.1371/journal.pmed. 
22. Stellzig A, Basdra EK, Kube C, Komposch G. Extraction therapy in patients with Class II/2 
malocclusion. J Orofac Orthop. 1999; 60:39-52. 
23. Stabrun AE, Danielsen K. Precision in cephalometric landmark identification. Eur J Orthod 1982; 4: 
185-96.  
24. Proffit WR, Fields HW, Sarver DM. Contemporary Orthodontics 4th Edition ed. St Louis: 
Mosby/Elsevier; 2007. 
25.  Glenny A-M, Harrison JE. How to…interpret the orthodontic literature.  J Orthod 2003; 30:159-64. 
26. NHS Centre for Reviews and Dissemination.  Undertaking Systematic Reviews of Research on 
Effectiveness: CRD’s guidance for carrying out of or commissioning reviews, 2nd edn.  York: NHS 
Centre for Reviews and Dissemination, University of York, 2001. 
27. Sackett  DL, Straus SE, Richardson WS, Rosenberg W, Haynes RV.  Evidence-based medicine: how to 
practice and teach EBM. Churchill Livingstone 2nd Ed; 2000. 
28. Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 
(updated September 2009). The Cochrane Collaboration. Available from www.cochrane-
handbook.org.2009. 
29. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, 
graphical test. BMJ. 1997; 315:629-34. 
30. Cleall JF, BeGole EA. Diagnosis and treatment of Class II division 2 malocclusion. Angle Orthod. 
1982; 52:38-60. 
 
31. Erickson LP, Hunter WS. Class II, division 2 treatment and mandibular growth. Angle Orthod. 1985; 
55:215-24. 
32. Pancherz H, von Bremen J. Outcome of Class II division 2 and Class II division 1 therapy using 
different treatment approaches. [abstract] Eur J Orthod. 2000; 22:455. 
33.  Kinzel J, Aberschek P, Mischak I, Droschl H.  Study of the extent of torque, protrusion and intrusion of 
the incisors in the contect of Class II, Division 2 treatment in adults.  J Orofac Orthop. 2002; 63: 283-
99. 
34. Moss JP. An investigation of the muscle activity of patients with Class II Division 2 malocclusion and 
the changes during treatment. Trans Eur Orthod Soc. 1975; 87-101. 
35. Demisch A, Ingervall B, Thuer U. Mandibular displacement in Angle Class II, division 2 malocclusion. 
Am J Orthod Dentofacial Orthop. 1992; 102:509-18. 
36. Ingervall B. Recording of retruded positions of mandible in children. Odontol Rev. 1968;19:65–82 
37. Thuer U, Ingervall B, Burgin W, Demisch A. No posterior mandibular displacement in Angle Class II, 
division 2 malocclusion as revealed with electromyography and sirognathography. Eur J Orthod. 1992; 
14:162-71. 
38. Woods MG. Sagittal mandibular changes with overbite correction in subjects with different mandibular 
growth directions: late mixed-dentition treatment effects. Am J Orthod Dentofacial Orthop. 2008; 
133:388-94.  
39. Stefani E. Veranderungen der Weichgewebe nach funktionskiefer-orthopadischer Behandlung im 
Fernrontgen-Seitenbild - eine statistische Untersuchung bei der Anomalie Angle-Klasse II, 2. Fortschr 
Kieferorthop. 1984; 45:49-54.  
40. Parker CD, Nanda RS, Currier GF. Skeletal and dental changes associated with the treatment of deep 
bite malocclusion. Am J Orthod Dentofacial Orthop. 1995; 107:382-93. 
41. Eberhard H, Hirschfelder U. Treatment of Class II, Division 2 in the late growth period. 0 J Orofac 
Orthop. 1998; 59:352-61.  
42. Björk A, Helm S. Prediction of the age of maximum puberal growth in body height. Angle Orthod. 
1967; 37:134-42. 
43.  Droschl D. Die fernröntgen werte unbehandelter kinder zwischen dem 6. und 15. Berlin-Chicago-
London-Rio de Janeiro-Tokio: Quintessenz; 1984. 
44. Kalavritinos MK. Dentoskeletal and esthetic changes of facial profile following activators treatment of 
Class II, Division 2 malocclusions. Hellenic Orthod Rev. 2001; 4:21-36. 
45. Zentner A, Peylo S, Brothag D. Predictive value of morphologic parameters for successful correction of 
Class II Division 2 malocclusion. Am J Orthod Dentofacial Orthop. 2003; 123:279-85. 
46. Honn M, Schneider C, Dietz K, Godt A, Goz G. Treating Class II patients with removable plates and 
functional orthopedic appliances-the importance of anterior tooth inclination and direction of growth on 
treatment outcome. J Orofac Orthop. 2006; 67:272-88. 
47. Tadic N, Woods MG. Incisal and soft tissue effects of maxillary premolar extraction in class II 
treatment. Angle Orthod. 2007; 77:808-16. 
48. Mills JR. The problem of overbite in Class II, division 2 malocclusion. Br J Orthod. 1973; 1:34-48.  
49. Binda SK, Kuijpers-Jagtman AM, Maertens JK, van 't Hof MA. A long-term cephalometric evaluation 
of treated Class II division 2 malocclusions. Eur J Orthod. 1994; 16:301-8. 
50.  Canut JA, Arias S. A long-term evaluation of treated Class II division 2 malocclusions: a retrospective 
study model analysis. Eur J Orthod. 1999; 21:377-86. 
51. Kim TW, Little RM. Postretention assessment of deep overbite correction in Class II Division 2 
malocclusion. Angle Orthod. 1999; 69:175-86. 
52. Lapatki BG, Klatt A, Schulte-Monting J, Stein S, Jonas IE. A retrospective cephalometric study for the 
quantitative assessment of relapse factors in cover-bite treatment. J Orofac Orthop. 2004; 65:475-88. 
53. Lapatki BG, Baustert D, Schulte-Monting J, Frucht S, Jonas IE.  Lip-to-incisor relationship and 
postorthodontic long-term stability of cover-bite treatment.  Angle Orthod. 2006; 76: 942-49. 
54. Devreese H, De Pauw G, Van Maele G, Kuijpers-Jagtman AM, Dermaut L. Stability of upper incisor 
inclination changes in Class II division 2 patients. Eur J Orthod. 2007; 29:314-20. 
55.  Bock N, Ruf S. Post-treatment occlusal changes in Class II division 2 subjects treated with the Herbst 
appliance. Eur J Orthod. 2008; 30:606-13. 
 
56.  Hagg U, Taranger J. Skeletal stages of the hand and wrist as indicators of the pubertal growth spurt.  
Acta Odontol Scand. 1980;38:187-200. 
57. Mandall N, DiBiase A, Littlewood S, Nute S, Stivaros N, McDowall R, et al. Is early Class III 
protraction facemask treatment effective? A multicentre, randomized, controlled trial: 15-month follow-
up. J Orthod. 2010; 37:149-61. 
58. Pjetursson BE, Tan WC, Tan K, Bragger U, Zwahlen M, Lang NP. A systematic review of the survival 
and complication rates of resin-bonded bridges after an observation period of at least 5 years. Clin Oral 
Implants Res. 2008; 19:131-41. 
59. Fleming PS, DiBiase AT. Systematic reviews in orthodontics: what have we learned? Int Dent J. 2008; 
58:10-4. 
60. Bollen AM, Cunha-Cruz J, Bakko DW, Huang GJ, Hujoel PP. The effects of orthodontic therapy on 
periodontal health: a systematic review of controlled evidence. J Am Dent Assoc. 2008; 139:413-22. 
61.  Cunningham S, Bearn D, Benson P, Johal A, Millett D, O’Brien K, Luther F.  In search of the sample: 
recent experiences of a trial team in orthodontics. Contemp Clin Trials 2011; 32: 530-4. 
62.  Meikle MC.  What do prospective randomized clnical trials tell us about the treatment of Class II 
malocclusions? A personal viewpoint.  Eur J Orthod 2005; 27:105-14. 
63.  O’Brien KD, Personal Communication. 2011. 
64. Litt RA, Nielsen IL. Class II, division 2 malocclusion. To extract--or not extract? Angle Orthod. 1984; 
54:123-38. 
65. Williams AC, Stephens CD. A modification to the incisor classification of malocclusion. Br J Orthod. 
1992; 19:127-30. 
66. Vig KW, Weyant R, O’Brien K, Bennett E.  Developing outcome measures in orthodontics that reflect 
patient and provider values.  Semin Orthod 1999; 5:85-95. 
67.  Warren JJ, Bishara SE. Comparison of dental arch measurements in the primary dentition between 
contemporary and historic samples. Am J Orthod Dentofacial Orthop. 2001; 119:211-5. 
68. Mossey P. Epidemiology underpinning research in the aetiology of orofacial clefts. Orthod Craniofac 
Res. 2007; 10:114-20.   
 
Legends for Tables and Figures   
 
Figure I 
 
Search flow (as described in the PRISMA statement) 21 
 
Tables 
 
Table I: Search strategies adopted for review of II/2M studies 
 
Table II: Excluded studies of II/2M with reason(s) 
 
Table III: Prospective studies of treatment for II/2M  
 
Table IV: Retrospective studies of treatment for II/2M 
 
Table V: Retrospective studies of stability for II/2M 
 
Table VI: Quality assessment and indication of risk of bias of studies of treatment (prospective case-control, 
prospective cohort, prospective case series, retrospective cohort) and stability (retrospective case-control, 
retrospective cohort) for II/2M. 
 PRISMA 2009 Flow Diagram  
 
 
303 records identified through 
database searching 
Sc
re
en
in
g 
In
cl
ud
ed
 
El
ig
ib
ili
ty
 
Id
en
tif
ic
at
io
n 
35 additional records identified 
through other sources 
 
322 records after duplicates removed 
 
322 records screened 
 
298 records excluded 
 
23 full-text articles  
(and one abstract) 
assessed for eligibility 
 
3 full-text articles  
(and one abstract) excluded, 
with reasons 
 
20 studies included in 
qualitative synthesis 
 
0 studies included in 
quantitative synthesis 
(meta-analysis) 
 
 
Table I Search strategies adopted for review of II/2M studies 
 
Database  Search history Results 
OHG reg* 1 ((Malocclusion* OR bite* OR 
Angle* OR class)  AND ("division 2" 
OR "div* 2" OR "div* II" OR "div* 
II")) 
2 
CENTRAL** 1 MALOCCLUSION, ANGLE CLASS 
II (Single term) 
1 
 2 (“class II” AND (angle* OR 
malocclusion* OR bite*)) 
 
 3 1 AND 2  
 4 “div* 2” OR “div* II”  
 5 3 AND 4  
MEDLINE 1 Malocclusion, Angle Class II/ 264 
 2 ("Class II" and (angle$ or 
malocclusion$ or bite$)).mp. 
[mp=title, original title, abstract, 
name of substance word, subject 
heading word] 
 
 3 or/1-2  
 4 ("div$ 2" or "div$ II").mp. [mp=title, 
original title, abstract, name of 
substance word, subject heading 
word] 
 
 5 3 AND 4  
EMBASE 1 exp Malocclusion/ 30 
 2 malocclusion* OR bite*  
 3 1 AND 2  
 4 ((angle* OR ('class 2' OR 'class ii')) 
AND ('division 2' OR 'division ii')) 
 
 5 3 AND 4  
 
* OHG TRIALS REGISTER 
** Cochrane central register of controlled trials 
 
 
 
Table II Excluded studies of II/2M with reason(s) 
 
Author/year Reason for exclusion 
RCS Cleall and BeGole 198230 Mean age not specified so unclear if subjects ≤18. 
RCoSErickson and Hunter 198531 Only 15 II/2M control subjects vs 34 (groups of 6, 14, 14) 
II/2M treated subjects 
RCSPancherz and von Bremen 200032                     
(Abstract) 
One of the two treated II/2M groups only 14 subjects vs 23 in 
other treated group; PAR assessment   
RCSTSKinzel et al 200233 Adult treatment; 25 cases but only 11 at follow-up 
 
RCoS, Retrospective cohort study matched to some “controls”; RCS, Retrospective case series; RCSTS, Retrospective case series of 
treatment and stability
 
Table III Prospective studies of treatment for II/2M 
 
Authors / 
year 
 
Study design 
 
No .of cases/ sex of subjects 
 
Mean age (range) 
Sample size  
calculation 
 
Setting/Operator 
 
Drop-out 
Definition  
of  
malocclusion 
Extraction/ non-extraction 
 
Treatment /duration 
 
Retention type/duration 
Mean time out of retention 
Error study Outcome measures (OM) /  Results ( R) 
 
Moss  
1975 34 
 
Cohort 
 
 
23 II/2M;  
11.9 SD 2.3 yrs 
 
22 control: normally 
developing occlusion  
 
No 
 
Not specified 
 
 
Ceph,3 drop out. 
 
EMG:8 drop out at end 
of tx and 4 more at least 
one year out of retention. 
 
Not stated 
 
Non-extraction 
 
Activator (some cases preceded by 
URA to procline UIs) 
15 recorded at end of tx; 11 
recorded at least 1yr out of retention 
 
Not stated 
 
Yes 
 
OM: ceph and EMG changes  
 
R:Pre-tx: anterior masseter activity > anterior temporalis; posterior 
temporalis slightly > posterior masseter 
Lower gonial angle associated with increased masseteric activity 
Distal displacement of jaw on closing in ~50% of cases 
 
Post-tx muscle activity more normal 
One case that relapsed: no change in muscle activity during tx or 
during retention 
 
Demisch et al 
199235 
 
Case series 
 
 
 
22 (11M, 11F) 
Median age pre-treatment 10yr 
2mo  
 
No 
 
 
University / 1 operator 
 
 
1 failed  to complete 
phase 2 and 3; tx 
discontinued due to lack 
of co-operation  
 
Bilateral distal occlusion 
with retroclined 
UI`(central); 
Large OB; 
No symptoms or signs of 
mandibular dysfunction  
 
 
Non-extraction 
 
 
2-phase tx (Phase1) Proclination of 
UI and bite raising with URA; 
(Phase 2) 
Herren activator for night-only 
wear  
 
 Median time (1) : 207 days  
 Median time (2) : 270 days 
 
 
Phase 3:  night only wear of 
modified retainer activator; median 
time 466 days 
 
Yes for  RCP-
ICP positions 
 
OM: ceph and recording of RCP/ICP in a  modified gnatho-
thesiometer. as described by Ingervall (1968)36 
 
R:median a-p difference between RCP and ICP: before tx 1.23 mm; 
after UI proclination 1mm; after activator  0.55mm; after retention 
0.95mm 
NS difference between before and after UI proclination: so mandible 
not posteriorly displaced. 
 
OB: median decrease of 3mm  with tx 
IIA: median decrease 15.20 with tx; median increase of 4.60 after 
retention 
UI: median increase 8.2o; after tx and further 0.50 after retention. 
LI: median increase 4.90 with tx and median decrease 4.40 after 
retention  
 
Thuer et al 
199237 
 
Case series 
 
 
As  for Demisch et al 1992 No 
 
As  for Demisch et al 
1992 
 
 
As  for Demisch et al 
1992 
As for Demisch et al 1992 Non-extraction 
 
 
As for  Demisch et al 1992 
Last recordings at 12 months with 
activator    
 
As for  Demisch et al 1992 
 
Yes  OM:  
EMG readings: 27 and 22 days before start of  tx; end of phase 1 
median time 207 days after start of treatment); 3 and 12 months after 
start of activator tx   
Sirognathograph recordings: position of mandible at rest, at 
intercuspation and during tooth contact during chewing and maximal 
mandibular movements  
 
R: Muscle activity unchanged during period of observation; activity 
decreased during maximal\biting, chewing and swallowing 
 
Positions of mandible at rest, at intercuspation, during chewing were 
stable during tx 
 
No signs recorded of anterior mandibular positioning during tx 
Woods 
200838 
 
Case-control 
 
 
Results based on: 
C: 93; 49F, 44M 
T: 92; 51F, 41M 
 
Dolicofacial* (facial axis 
<870) 
C= 19; mean age 11.5 SD 1 
yr)  
T= 15; mean age 11.6 SD 1.1 
yr 
 
Mesofacial (facial-axis 87-
930) 
C= 38; mean age 12 SD 1.2 yr 
T=39; mean age  
12 SD 1.2 yr 
 
Brachyfacial (facial axis > 
930) 
C=36; mean age 11.5 SD 1yr 
T= 38; mean age 11.2 SD 
1.1yr 
No 
 
Not stated 
 
All treated by an 
experienced 
orthodontist 
using consistent 
treatment regimen 
 
Drop outs for various 
reasons but not 
specified 
 
UI to NA <180 
 
Overbite > 5mm; 
> 5mm Class II molars; 
<5mm mandibular arch 
crowding 
Non-extraction 
 
U/L FA with HG (Ricketts 
mechanics) 
 
C= min 2.5yr 
 
Dolicofacial* 
T=2.5 yr 
Mesofacial 
T=2.4 yr 
Brachyfacial 
T=2.2 yr  
 
 
Retention not specified 
 Yes OM: Ceph 
assessment of sagittal mandibular changes with overbite 
correction with different mandibular growth directions 
 
Mean changes during active treatment or a minimum 30-month 
control period 
 
No evidence of sexual dimorphism for point B or Pog change 
(control or treatment),  results were pooled 
 
R: Mean point B change significant for Mesofacial (C=2.6 SD 
1.6mm; T=6.8 SD 2.1mm; p<0.01) 
Brachyfacial (C=2.6 SD 2.3mm, T=8.2 SD 1.9mm;  p<0.01) 
 
Mean Pog change significant for Brachyfacial  8.3 SD 2.4mm; 
p<0.05  
           
II/2M, Class II division 2 malocclusion; SD, standard deviation; yr, year; Ceph, lateral cephalometric radiograph; EMG, electro-myographic; URA, upper removable appliance; UI,upper incisor; tx, treatment; M, male; F, female; mo, month; 
OB, overbite; RCP-ICP, retruded contact position to intercuspal position; a-p, antero-posterior; NS, non-significant; IIA, inter-incisal angle; LI, lower incisor; C, Control; T, Treatment; *not considered for evaluation as  < 20 subjects in both 
C and T groups; UI to NA, upper incisor angulation to Nasion-A line; U/L FA, Upper and lower fixed appliances; HG, headgear; Pog, Pogonion. 
 
 Table IV Retrospective studies of treatment for II/2M 
 
Authors / 
year 
 
Study design 
 
No. of cases 
 
Mean age (range)/ 
sex of subjects 
Sample 
size  
calculation 
 
Setting 
 
Drop-out 
 
Definition  
of  
malocclusion 
Extraction/ non-extraction 
 
Treatment  / duration 
 
Retention type/duration 
 
Error study Outcome measures (OM) /  Results (R) 
 
Stefani  
198439 
 
Case series 
 
 
 
 
 
 
34 
 
Mean age/gender of subjects 
n/g 
 
 
 
 
 
 
No 
 
University clinic 
 
No 
 
Not given  
 
Non-extraction 
 
Removable functional appliances 
 
Not stated 
 
 
No  
 
 
 
 
 
 
 
 
OM:  ceph changes.  
 
R: Soft tissue profile changes 
 
 
 
 
 
 
Parker et al  
199540 
 
Cohort 
 
 
 
44 II/2M 
 
27 II/1M 
 
61 Class 1 
 
Age range entire sample: 11 yr 
to 15yr 9mo 
 
 
 
 
No 
 
 
Private Practice 
 
No drop-outs 
recorded 
 
Angle 
classification; At  
least 70% 
anterior OB 
 
II/2M: 33 non-extraction; 11 extraction 
II/1M:17 non-extraction; 10 extraction 
Class I: 35 non-extraction; 26 extraction 
 
Six treatment modalities to reduce  OB 
Average tx time entire sample: 31 mo (range 14 to 48)  
 
Not stated 
 
 
Yes 
 
 
OM: skeletal and dental changes with OB tx assessed on cephs 
and dental casts  
 
R: mean tx changes for II/2 sample 
OB: mean decrease ~5mm  
LI to NB: mean decrease ~7.60  
UI to SN: mean increase ~14.70  
IIA: mean decrease by ~220   
 
LAFH increased significantly (mean 3.2mm ) with all tx 
mechanics  
 
For extraction vs no-extraction II/2M : maxillary  6 to SN line in 
mm and maxillary 6 to  perpendicular  to the SN line at S were 
significant. 
LI intrusion only found in 38% of II/2M 
  
 
 
Eberhard and 
Hirschfelder 
199841 
 
Case series 
22 (12M; 10F) 
 
Mean age start: M 14 SD 0.9 yr; 
F 12.3 SD 0.4 yr)  
 
 
 
 
 
 No 
 
Not specified 
 
No drop-outs 
recorded 
II/2M 
Ob>4mm 
Ml-NL <18 Ar-Go-
Me < 118 
Growth 
stage:DP3U 
(Bjork).42 
Not specified. 
 
Herbst and UFA 6.4 SD 0.2 mo; then after  Herbst 
removal, LFA fitted (before Herbst 6M, 4F 
unsuccessfully treated with removable appliances) 
-records taken at start of tx, at about 6mo later on 
removal of Herbst and again 6mo later 
 
Retention: Class II elastics worn for 24 hrs per day, 
later reduced if permissible. 
Not stated  
 
 
 
 
 
 
 
 
OM: changes with tx assessed with cephs/study casts/dpts 
 
R: IIA: mean decrease by 190  (after 6 mo removal of Herbst, 
mean change of 1.9n)   
Significant improvement in vertical jaw base relationship stable 
after 12 months 
Intrusion of upper 6’s and lower 4’s observed; minor protrusion 
of lower incisors 
 
Stellzig  
et al  
199922 
 
Cohort 
Gp1: 20 (8M; 12F) 
mean age start 11.1 yr 
mean age end 15.3 yr 
 
Gp2: 20 (8M; 12F) 
Mean age start 13.1yr 
Mean age end 15.3 yr  
 
Control: 20 untreated II/2M 
from Belfast Growth Study 
(ages 9-15 yrs) 
No 
 
Not stated 
 
No drop-outs 
recorded 
UI-SN of 1SD 
below mean of 
Class I occlusion 
patients of same 
age from study of 
Droschl 1984.43 
 
For control: 
II/2M 
ANB>4° 
UI-SN <96° 
Gp1: extraction of 4x4  
19 treated with U/L FA  
(15 also wore H/G) 
1 treated with functional; 
Class II elastics also used with FA; 
intrusion mechanics used in 17 subjects for 
overbite reduction 
 
Gp2: extraction of 7’s 
19 treated with U/L FA 
1 treated with functional; 
all wore HG 
intrusion mechanics used in 4 subjects for overbite 
reduction 
 
Mean tx duration 
Gp1: 4.2 yrs  
Gp2: 2.2 yrs 
 
Retention not stated 
 
Yes OM: Ceph/ study model/ dpt changes 
 
R: Treated vs untreated: 
Gp1: significant marked recession of upper lip 
IIA: only slight decrease (3.9°) 
OB: mean decrease 2.3mm 
 
Gp 2: Only slightly increased flattening of upper lip 
IIA: mean decrease (12.6 °) to value approaching controls 
(131.5°) 
OB: mean decrease 2.9mm 
 
*After premolar extraction, renewed spacing present in 41% 
of cases 
 
Kalavritinos  
200144 
 
Case series 
39 (13M; 17F) 
 
Mean age start: 
M 10yr: F 8 yr 10mo 
 
 
 
 
 
No 
 
University 
 
No drop-outs 
recorded. 
UI palatal 
inclination; 
decreased values 
for facial angle, 
SNB, SNPg, 
reduced lower 
facial height 
Non-extraction 
 
Activator only (Andresen-Haupl) with UI  0.7mm 
protrusion spring 
Cases treated 1962-1982 
Mean duration: M, 3.7yrs; F, 3.5 yrs 
 
Not stated 
Yes 
 
 
 
 
 
 
 
 
 
OM: dentoskeletal and soft tissue changes with activator 
treatment assessed on cephs 
 
R: UI to maxillary plane: mean increase during tx ~40; 
LI to anterior margins of maxilla and mandible:  
mean increase during tx ~20  
Mean  increase 1.40 with tx in  SNPg 
 
Zentner et al 
200345 
 
Case series 
 
96 
 
Average age start: 12.16 SD 
4.03 yr 
 
 
No 
 
Not specified 
 
No drop-outs 
recorded. 
Distal molar 
relationship, 
increased ob, 
retroclined UI  
 
Not stated 
 
Various removable and fixed appliances and 
combinations of these. 
Tx and retention: 49.83 SD 18.66 mo 
 
Not stated 
 
Yes  
 
OM: Angular and linear changes on ceph / % PAR score change 
on study casts 
 
R: Maxillary apical base size strongest predictor of occlusal 
correction (%PAR reduction) 
Honn et al 
200646 
 
Cohort 
Gp1: 50 II/2M  
(Growth pattern: 14 horizontal; 
11 neutral; 25 vertical) 
Mean age at start: 9yr 9mo 
(25M; 25F) 
31 treated with U/L FA 
 
Gp2: 50 II/1 
(growth pattern: 17 horizontal; 
15 neutral;18 vertical) 
Mean age start: 9yr 11mo 
(25M,25F) 
32 treated with U/L FA  
 
Classified by SN-MeGo angle: 
<31: horizontal 
>33: vertical  
In between: neutral 
 
No 
 
University (30 
patients) and two 
Private Practices 
(70 patients) 
 
No drop-outs 
recorded 
Angle  
distocclusion least 
one premolar width 
in first molar 
region; 
UI-SN < 95 
degrees 
 
Not stated. 
 
URA for expansion 7 mo maximum; then activator  
median tx time: Gp1:with URA/ activator 3yrs 
Gp2: 3yrs3mo 
 
Not reported 
Yes OM: anterior tooth inclination and growth pattern effects assessed 
on cephs 
 
R: OB: mean decrease with tx 1.9mm; 2.9mm; 1.6mm (for 
horizontal, neutral, vertical growth patterns); significant in neutral 
and vertical subgroups. 
 
IIA: mean decrease with tx 5.80, 9.30, 5.20 (horizontal, neutral, 
vertical growth patterns) 
 
 
 
Tadic and 
Woods  
200747 
 
Cohort 
22 II/2M 
(12F: 10M) 
Mean age start: 14.5 SD 2.4yr 
(F:14.5 SD 2.5yr 
M:15.5 SD 2.8yr) 
 
39 II/1M 
(18F, 21M)  
Mean age start: 13.3 SD 1.9yr 
(F: 13.0 SD 2.1yr M: 14.0 SD 
1.5yr) 
 
  
No 
 
Not specified; one 
experienced 
operator using 
consistent  
biomechanics 
 
No drop-outs 
recorded 
Minimal crowding 
upper and lower 
arches 
 
Class II 
Mesiobuccal cusps 
of both upper 6’s 
occluded at least 
5mm anterior to 
the midbuccal 
grooves of the 
lower 6’s 
  
II/2M: UI < 180 to  
N-A line  
 
II/1M: UI > 180 to  
N-A line  
 
Extraction of upper premolars 
U/L FA  
 
 
Duration not stated 
 
Not stated 
Yes OM:UI and soft tissue lip changes on cephs 
 
R: UI to N-A line: S diff in mean changes for II/2M (~+8.000) 
and II/1M (~-3.000) and for male and female groups per 
malocclusion.  
UI distance to N-A Line: S diff for II/2M (+1.3mm) and II/1M (-
1.88mm) groups. 
 
NLA change: wide variation among subjects in all groups; mean 
increase for II/2M:2.530  and II/1M 4.280; NS difference between 
groups. 
Mean decrease in upper and lower lip curve (II/2M: 0.19mm; 
II/1M:- 0.21mm) respectively; NS difference between groups. 
 
 
n/g, not given; Ceph, lateral cephalometric; II/2M, Class II division 2 malocclusion; yr, year; mo, month; OB, overbite; II/1M, Class II division 1 malocclusion; Tx, treatment; LI, lower incisor; NB, Nasion-B point line; UI, upper incisor; 
SN, Sella-Nasion line;  IIA, interincisal angle; LAFH, lower anterior facial height; M, male; F, female; SD, standard deviation; Ml-NL, maxillary-mandibular plane angle;  Ar-Go-Me, Articulare-Gonion-Menton; DP3U, epiphyseal union of 
distal phalanx of the third finger; U/L FA, upper and lower fixed appliances; dpt, dental panoramic tomogram; ANB, measure of antero-posterior skeletal pattern; HG, headgear; SNB, Sella-Nasion-B Point; SNPg, Sella-Nasion-Pogonion; 
PAR, Peer Assessment Rating index; SN-MeGo, sella-nasion / menton to gonion angle; URA, upper removable appliance; N-A, Nasion to A point line; NLA, naso-labial angle 
 
                    
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table V Retrospective studies of stability for II/2M 
 
Authors / year 
 
Study/design 
 
No .of cases/ sex of subjects 
 
Mean age (range) 
Sample size  
calculation 
 
Setting/ 
Operator 
 
Drop-out 
Definition  
of  
malocclusion 
Extraction/ non-extraction 
 
Treatment /duration 
 
Retention type/duration 
Mean time out of retention 
Error study Outcome measures (OM) /  Results ( R) 
 
Mills 
197348 
 
Case series 
 
 
 
 
60 (21M; 39F) 
 
Age 11.7 SD 2.4 yrs 
 
Age 17.9 SD 2.5 yrs 
Compared* with 9 year (13M; 
10F) and 14 year (9M; 15F) 
control of London 
schoolchildren 
 
No 
 
University  
 
N/R 
 
UI <100 to maxillary plane 
 
OB >3mm 
 
UI in contact on their lingual 
side with lowers i.e. no 
overjet increase  
 
Not stated  
 
Not stated 
 
Time out of retention: 
3.13 SD 1.9 yrs 
 
Not stated 
 
OM:  factors influencing  successful treatment outcome 
 
R: Based on cases with >70 mean proclination (28UI and 30 LI cases, 
many cases of both)  
Mean UI proclination during tx (~130 ) of which mean 8° maintained 
after retention, relapse of ~37%; 
Mean LI proclination during tx of ~ 120 of which 100 maintained 
after retention, relapse of ~17% 
 
Large SD for both angulation changes; relapse usually associated 
with a return of incisor crowding   
 
Successful OB reduction correlated with reduction in IIA (~0.7 CC), 
relative lowering of lower lip line (~0.5 CC) and growth of lower 
face ( ~0.5 CC). Proclination LI generally more successful than UI. 
Binda et al  
199449 
   
Case series 
 
 
81 (42M; 39F) 
Mean age pre-tx 13.6M; 
13.2F 
 
Post-retention (as above)  
 
2yrs post-retention 
(33M; 32F) 
Mean age 19.4M; 19.5F 
 
5 yrs post-retention (24M; 
20F) 
Mean age 23.8M; 21.5F)  
No 
 
University 
 
N/R 
Disto-occlusion and 
retroclination of two or more 
UI 
Not stated 
 
EOT or Functional and U/L 
FA (Edgewise) or sectional 
edgewise therapy 
Duration: not stated 
Type and duration: not stated 
 
Records at 2 and 5 years 
post-retention 
Yes OM:  Post-retention changes in skeletal, dental, soft tissue variables 
 
R:  OB: mean decrease 3.9mm (pre-tx to end of retention), mean 
increase 0.8mm (2 yrs post-retention) and 1.2mm (5 yrs post 
retention) 
IIA: mean decrease ~160 (pre-tx to end of retention), mean relapse  
3.60 (2 yrs post-retention) and mean relapse ~ 60 (5 yrs post-
retention) 
ALFH: mean increase 4.7mm (pre-tx to end of retention), mean 
increase 0.6mm (2yrs post-retention) and1mm (5 yrs post-retention). 
UI to SN: mean increase 10.60 (pre-tx to end of retention); 
mean decrease 0.90 (2 yrs post-retention)  and 1.60 ( 5 yrs post-
retention)   
LI to Mand plane: mean increase 5.80(pre-tx to end of retention); 
mean decrease 2.10 (2 yrs post-retention) and 2.60 (5 yrs post-
retention) 
 
Skeletal variables changes: M> F; younger> older; anterior growth 
rotation indicated post-retention 
Lower lip cover of UI: mean decrease 1.2mm from start of tx to post-
retention  
Post-retention: OB and IIA increased significantly 
Horizontal and vertical growth of soft tissues during tx but un-
remarkable after tx except nose and chin became more prominent.   
 
 
Canut and 
Arias  
199950 
 
Case series 
 
 
30 (20F; 10M) 
Mean age pre-treatment 12 
SD 2.8 yrs 
 
Mean age post-retention 22.2 
SD3.6 yrs  
No 
 
Not given 
 
N/R 
Disto-occlusion and 
retroclination of >2 upper 
incisors  
Non-extraction 
 
Routine edgewise 
3 SD 1.2 years  
 
Type not given 
Mean duration 3 SD 1.2 yrs 
Minimum 3 years out of 
retention 
Mean period out of retention 
7  SD 2.8 yrs 
Yes OM: long-term changes in occlusion, alignment and arch dimensions 
measured on study casts 
 
R:  molar relationship stable:  mean relapse 0.6 post tx 
OB: mean decrease 3.5mm during tx; mean increase 0.96mm post-tx;  
(~26% relapse) ; over-correction of OB relapsed 
 
Mean maxillary 3-3 expansion with tx: ~2.4mm; no decrease post-
retention  
Mean maxillary  intermolar increase with tx: 2.3mm; mean decrease 
0.8mm post retention 
Anterior maxillary crowding: mean decrease with tx ~4mm; mean 
increase 0.8mm post retention 
10% of maxillary arch unacceptable (Irregularity Index >4.5mm) 
anterior irregularities post-retention  
 
Mean mandibular 3-3 expansion with tx: 1.3mm; mean 1.1 decrease 
post retention 
Mean mandibular intermolar increase with tx: 1.2mm; mean decrease 
0.6mm post retention. 
Increase in lower 3-3 width > 1mm and arch length always relapsed 
with associated crowding (30% unacceptable post-retention; 
Irregularity Index >2.5mm) 
 
OB overcorrection group, no net improvement long-term. Lower arch 
pre-tx crowding related to post-tx crowding. 
Number of years post-retention, OB relapse and lower post-retention 
crowding linked   
 
 
Kim and Little 
199951 
 
Case-control 
 
 
 
62 (31M; 31F) 
Mean age at start of tx 12.7yr 
(SD 2.6); at the end of tx 
15.7yr (SD 2.4); long-term 
post-retention 30.9yr (SD 5) 
 
GP1: 33 
OB> 4mm post-retention 
(mean 5.17, SD 0.87mm) 
 
GP2: 29 
OB <4mm post-retention 
(mean 2.95, SD 0.87mm) 
 
cases selected at end of tx 
with initial deep OB and 
successful orthodontic tx 
judged clinically at end tx 
 
No 
 
University 
 
N/R 
 
II/ 2M, OB >4mm 
 
29 non-extraction 
23 extraction first premolars 
10 extraction other than first 
premolars 
 
U/L FA Edgewise technique 
Duration: not stated 
 
Type: not given 
Duration: not given 
Mean time out of retention 
15.2 years SD 4.5 yrs 
    
Yes 
 
OM:  long-term stability of deep OB correction assessed on cephs 
and dental casts;  predictors of post-retention OB  
 
R: mean OB decrease during tx 3.5mm ; mean relapse 1.4mm (40%) 
LAFH: mean increase during tx 4.1mm; mean relapse 1.4mm 
(~40%) 
IIA: mean decrease with tx 12.30; mean relapse 7.20 (~59%);  
 
Molar relationship: mean change with tx 3.1mm; mean relapse 
0.1mm 
LII: mean decrease with tx 4mm; mean relapse 2.6mm (65%) 
UII: mean decrease with tx 7.7mm; mean relapse 1.2mm (~16%) 
 
Long term OB changes very variable; chance of maintaining OB < 
4mm was 50% 
NS interaction between sex of patient and relapse. Tooth extraction 
does not seem to cause increase in post-tx OB. 
 
Initial OB best predictor of post-tx OB (R2 = 0.42) but other factors 
could be involved. 
 
 
Lapatki et al  
200452 
 
Case series 
 
 
 
 
40 (8M, 22F) 
Mean age pre-tx 10.0 yrs (6.8 
to 47.9 yrs); tx started in 
mixed dentition in 29 of 40 
patients 
 
 
No 
 
University clinic 
 
N/R 
 
 
 
UI <98 degrees to anterior 
cranial base; OB <4mm 
 
Non-extraction (26) 
U4’s (11); U5 (1); U6 (1) 
U2 (1) 
 
Active tx started in mixed 
dentition (29) 
6 URA solely; 28 removable 
and fixed; 6 fixed appliance 
only 
Duration: not stated 
 
Type not given  
Duration:\not given 
Median post-tx period: 2 yrs 
(1.1 to 5 years) 
 
Yes 
 
OM: relapse factors especially significance of a high lower lip line  
in comparison with other potential relapse factors assessed on cephs 
 
R:  Only given for the 29 patients who started treatment in the mixed 
dentition.1 
median UI to SN change with treatment: 5.80; median change post-
treatment -.80; relapse  ~14%. 
  
 
OB: median  change with treatment -2mm; median change post-
treatment 0.5mm; relapse 25% 
 
Substantial inter-individual variation in UI and OB changes. 
Increased relapse tendency associated with: maxillary extractions,  
pronounced treatment induced UI inclination change, high post-tx 
lower lip line, poor compliance in retention phase 
 
 
Lapatki et al  
200653 
 
Case series 
 
 
31 (14M; 17F) 
Mean age pre-treatment 10.6 
(7.0-33.9 yrs) 
 
(27 ≤ 18 yrs)1 
 
No 
 
University clinic 
 
From 113 former 
patients 43  were 
contacted and 31 
agreed to participate 
Pre-tx retroclined maxillary 
incisors (<98 degrees to 
anterior cranial base), OB > 
3mm;  
Non extraction (25) 
Extraction (6)  
                               
Not stated 
 
Removable plates (13) ; 
Removable plates followed 
by vacuum formed stents (5); 
positioners or activators (5); 
bonded wire retainers (1) 
7 pts discontinued retention 
shortly after tx was finished. 
Average retention period 
median) 1.3 yrs (0-15.2 yrs) 
Post-tx follow up median 9 
yrs (3.4 to 15.2 yrs) 
 
 
Yes OM: impact of persisting high lip line and other potential relapse –
inducing factors on long-term stability of orthodontic correction of 
retroclined UI assessed on dental casts and cephs. 
 
R: Only given for the 27 patients who started treatment in the mixed 
dentition.1 
median decrease in OB with treatment 1mm and median relapse 
0mm median change of 70  in UIA to occlusal plane during tx; mean 
relapse 0.50 (~7% ) 
Large inter-individual variability in post-tx UIA change (-5.25° to 
+6.75°). 
 
Increased  tendency to relapse (a) where high post-tx lip 
line level is combined with UI and lower lip contact only in incisal 
crown area  (b) marked tx induced UI inclination changes  
 
 
Devresse et al  
200754 
 
Case series 
 
 
61 (31M; 30F) 
Mean age: 13.4 SD 4.4 yrs 
 
 
No 
 
University 
 
N/R 
 
Class II molar relationship 
and obvious retroclination of 
both UI (central); competent 
lips on ceph 
 
Not stated 
 
U/L FA  
Many tx 2-phase 
(removable/FA) 
Tx plan varied by 
malocclusion 
Mean  
treatment time 3.5 SD 1 yr 
 
Hawley retainer (18M; 13F) 
Upper lingual retainer (13M; 
17F) 
Duration: not given 
Mean 3.5 years post-tx 
 
Yes 
 
OM:  change in incisor inclination following tx; long-term stability 
after retention assessed on dental casts and cephs 
 
R: Mean change of 15.20 in UI inclination during tx; mean  relapse of 
2.2 ° (~14%) independent of type of retention appliance 
 
More UI proclined and torqued during tx, more relapse afterwards. 
 
Mean decrease in lip line height of 0.6mm at end of tx (statistically 
significant but deemed not clinically significant). 
 
Bock and Ruf 
200855 
 
Cohort 
 
 
 
37 (18M; 19F) 
 
3 growth periods: 
Early adolescent: 
7F 12.1-14.4yr; 3M 11.3-
13.2yr 
Late adolescent: 6F 12.2-15 
yr; 8M 14.1-16.4 yr 
Adult: 6F 16.8-36.5; 7M 
16.3-25.6 
 
 
 
 
 
No 
 
University 
 
N/R 
 
Class II molar 
(>0.5mm) 
Bilaterally or  
>1 cusp   
width 
unilaterally;  
ob>3mm;  
retroclined 
UI (centrals) 
 
Non-extraction 
 
2 phase tx: 
Herbst/ 
Tip-Edge/multibracket 
 
Average tx duration:  
each phase 
7.5 mo;   
11 mo 
 
Activator(10), Upper 
Hawley(17) and fixed lower 
3-3 lower fixed(27) 
Activator (5), U and L 
Hawley (1), positioner (3) 
Upper 3-3 / lower 3-3 fixed 
(1)  
Average retention time 27 
SD 13.3mo  
 
 
 
2 authors 
performed 
evaluations 
and mutually 
agreed 
 
OM: post-tx occlusal changes on dental casts in early adolescent, late 
adolescent and adult subjects treated with Herbst (assessment of tx 
growth period using handwrist radiographs and method of Hagg and 
Taranger)56 
 
R: After 27 mo retention (average) and only those given for early and 
late adolescents. 
 
OB: early adolescent: mean decrease with tx ~3.6mm and increase 
post-tx ~0.8mm.(~22% relapse) 
Late adolescent: mean decrease with tx 4.7mm and increase post-tx 
0.9mm (~19 % relapse) 
early and late adolescent combined: mean decrease with tx ~4.2mm 
and increase post-tx ~0.9mm.(~21% relapse)2 
 
 
Molar relationship: early adolescent 5%; late adolescent 7% 
combined. ~12% relapse.2 
 
 
 
M, male; F, female; SD, standard deviation; *comparison only for aetiology but not for treatment; N/R, not relevant; UI, upper incisor; OB, overbite; yr, year; LI, lower incisors; CC, correlation coefficient; tx, treatment; EOT, extra-oral 
traction (headgear); U/L FA, upper and lower fixed appliances; IIA: inter-incisal angle; Ceph, lateral cephalometric radiograph; LAFH, lower anterior facial height; SN, Sella-Nasion,;  Mand plane, mandibular plane; LII, lower irregularity 
index; UII, upper irregularity index; NS, non-significant; R2, regression co-efficient; URA, upper removable appliance; 1,  Results kindly supplied by Prof. Lapatki; UIA, upper incisor angulation; mo, months; 2, Results kindly supplied by 
Dr. Bock and Prof. Ruf.                                           
 
 
 
 
 
 
Table VI (a) Quality assessment and (b) indication of risk of bias of studies of treatment (prospective case-control, prospective cohort, prospective case 
series, retrospective cohort) and stability (retrospective case-control, retrospective cohort) for II/2M   
(a) 
 
Quality assessment factors  Moss  
197534  
Demisch et al 
199235 
Thuer et al  
199237 
Parker 
199540 
Kim and 
Little 
199951 
Stellzig et al 
199922 
Honn 
200646 
Tadic and 
Woods 
200747 
Woods  
200838 
Bock and Ruf 
200855 
Sample size reported 
 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Sample size based on power 
calculation 
 
No No No No No No No No No No 
Eligibility criteria described 
 
No Yes Yes Partial Yes Yes Yes Yes No Yes 
Random allocation to groups 
 
No No No No No No No No Unclear No 
Treatment allocation concealed 
 
No No No No No No No No Unclear No 
Baseline equipoise between 
groups 
 
Unclear N/R N/R No Age not 
gender 
No No No Yes N/A 
Blinding of treating clinician 
to treatment allocation 
 
No No No no No No No No No No 
Blinding of patients to 
treatment allocation 
 
No No No No No No No No No No 
Outcome assessors blinded to 
treatment allocation 
 
No No No No No Unclear No No Unclear No 
Point estimates and measure of 
variability presented for  
primary outcome measures 
 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Appropriate statistical methods 
used to compare groups 
 
Unclear N/A N/A Unclear Yes Unclear Unclear Yes Unclear Unclear 
Intention to treat analysis used No No No No No N/A No No Unclear No 
 
Selective reporting 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Unclear 
 
Yes 
Key: N/R= not relevant; N/A= not applicable 
 
(b) 
Trial Adequate 
sequence 
generation 
Allocation 
concealment 
Blinding of 
participants  
Incomplete 
outcome data 
addressed 
Blinding of 
outcome 
assessors  
Free of 
selective 
reporting 
Free of other 
bias 
Risk of bias 
Moss  
1975 34 
 
No No No No No No No High 
Demisch et al  
199235 
 
No No No No No No No High 
Thuer et al  
199237 
 
No No No No No No No High 
Parker 199540 
 
No No No No No No No High 
Kim and Little 
199951 
 
No No No No No No No High 
Stellzig et al 
199922 
 
No No No No Unclear No No High 
Honn 200646 
 
No No No No No No No High 
Tadic and 
Woods 200747 
 
No No No No Unclear No No High 
Woods 200838 
 
Unclear Unclear No No Unclear Unclear No High 
Bock and Ruf 
200855 
No No No No For skeletal 
maturity 
No No High 
 
 
